LMNA基因变异与成人起心脏病风险
在185,990名英国生物银行全外显子测序参与者中,1,167人(0.63%)携带罕见LMNA变异,中位随访10.9年。LMNA功能评分与心律失常或心肌病风险相关(OR 2.21),核定位信号上游变异关联更强(OR 5.05)。携带者发病率8.43/1000人年,非携带者6.38/1000人年。
要点
- 罕见LMNA变异携带者心律失常或心肌病风险增加。
- 核定位信号上游变异风险关联更强。
- 仅少数LMNA变异在ClinVar中被报告为致病性。
核心结论
- 中年成人携带罕见错义或功能缺失LMNA变异者心律失常和心肌病风险增加。
研究设计与样本
- 基于英国生物银行185,990名参与者的全外显子测序数据,中位随访10.9年。
主要发现
- 1,167名(0.63%)参与者携带LMNA变异,15,079名(8.11%)发生心律失常或心肌病事件。
- LMNA评分与心律失常或心肌病相关(OR 2.21;P < 0.001)。
- 限制于核定位信号上游变异时关联更显著(OR 5.05;P < 0.001)。
- 携带者心律失常或心肌病发病率为8.43/1000人年(95% CI 6.73-10.12),非携带者为6.38/1000人年(95% CI 6.27-6.50)。
- 仅3个(1.2%)变异在ClinVar中被报告为致病性。
临床怎么用
- 对携带罕见LMNA变异的中年成人应加强心律失常和心肌病风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genetic variants in LMNA may cause cardiac disease, but population-level contributions of variants to cardiac disease burden are not well-characterized. OBJECTIVES: We sought to determine the frequency and contribution of rare LMNA variants to cardiomyopathy and arrhythmia risk among ambulatory adults. METHODS: We included 185,990 UK Biobank participants with whole-exome sequencing. We annotated rare loss-of-function and missense LMNA variants for functional effect using 30 in silico prediction tools. We assigned a predicted functional effect weight to each variant and calculated a score for each carrier. We tested associations between the LMNA score and arrhythmia (atrial fibrillation, bradyarrhythmia, ventricular arrhythmia) or cardiomyopathy outcomes (dilated cardiomyopathy and heart failure). We also examined associations for variants located upstream vs downstream of the nuclear localization signal. RESULTS: Overall, 1,167 (0.63%) participants carried an LMNA variant and 15,079 (8.11%) had an arrhythmia or cardiomyopathy event during a median follow-up of 10.9 years. The LMNA score was associated with arrhythmia or cardiomyopathy (OR: 2.21; P < 0.001) and the association was more significant when restricted to variants upstream of the nuclear localization signal (OR: 5.05; P < 0.001). The incidence rate of arrhythmia or cardiomyopathy was 8.43 per 1,000 person-years (95% CI: 6.73-10.12 per 1,000 person-years) among LMNA variant carriers and 6.38 per 1,000 person-years (95% CI: 6.27-6.50 per 1,000 person-years) among noncarriers. Only 3 (1.2%) of the variants were reported as pathogenic in ClinVar. CONCLUSIONS: Middle-aged adult carriers of rare missense or loss-of-function LMNA variants are at increased risk for arrhythmia and cardiomyopathy.
引用
- Lazarte J, Jurgens SJ, Choi SH, et al. LMNA Variants and Risk of Adult-Onset Cardiac Disease. J Am Coll Cardiol. 2022. PMID: 35772917. doi:10.1016/j.jacc.2022.04.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。